# FDA Inspection 1121894 - Bloodworks - March 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/0cdb913e-e16e-4ad8-a98c-55ca440cb749
Source feed: FDA_Inspections

> FDA Inspection 1121894 for Bloodworks on March 11, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121894
- Company Name: Bloodworks
- Inspection Date: 2020-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1226001 - 2023-12-21](https://www.keypedia.com/records/fda_inspections/bloodworks/bb954277-fe07-4cd5-8eb2-f7281990ab70)
- [FDA Inspection 1121894 - 2020-03-11](https://www.keypedia.com/records/fda_inspections/bloodworks/d0aa21ff-22bd-49f0-9486-d8d83473739d)
- [FDA Inspection 1039397 - 2017-12-18](https://www.keypedia.com/records/fda_inspections/bloodworks/f34f52b4-3111-4edd-ae31-93986f3e2b84)
- [FDA Inspection 983238 - 2016-08-24](https://www.keypedia.com/records/fda_inspections/bloodworks/62470581-e1af-46a3-af42-193a45f42d54)

Company: https://www.keypedia.com/companies/bloodworks/e909150b-e91d-4bf5-8fb1-51eb51be0393

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d